Optogenetic Therapy

Optogenetic Therapy is a form of ocular gene therapy that involves the genetic introduction of light-sensitive proteins into retinal cells to restore light responsiveness in degenerated photoreceptor layers, thereby enabling visual signal transduction through targeted optical stimulation.

305

Publications

23.9K

Citations

1.7K

Authors

553

Institutions

Publications per year

2017–2026

167

Authors

1.7K

  1. SP
    Serge Picaud

    Inserm, France

    11 publications · 1.8K citations

    11

    h-index

  2. JS
    José‐Alain Sahel

    Inserm, France

    12 publications · 1.8K citations

    11

    h-index

  3. KD
    Karl Deisseroth

    Stanford University, United States

    12 publications · 2.9K citations

    11

    h-index

  4. JD
    Jens Duebel

    Institut de la Vision, France

    10 publications · 1.6K citations

    10

    h-index

  5. DD
    Deniz Dalkara

    Institut de la Vision, France

    10 publications · 1.6K citations

    10

    h-index

1–5 of 1.7K

Venues

  1. Scientific Reports

    10 publications · 484 citations

    10

    h-index

  2. Proceedings of the National Academy of Sciences

    PNAS · 9 publications · 1.5K citations

    9

    h-index

  3. Investigative Ophthalmology & Visual Science

    IOVS · 8 publications · 504 citations

    8

    h-index

  4. Nature Communications

    8 publications · 837 citations

    8

    h-index

  5. PubMed

    Repository · 7 publications · 161 citations

    7

    h-index

1–5